Published in Clin Diagn Lab Immunol on November 01, 1994
Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J Clin Microbiol (1995) 1.01
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection. Sex Transm Infect (1998) 0.89
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Heterogeneity of the human papillomavirus group. J Virol (1989) 4.90
Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and southern-blot analysis. J Med Virol (1989) 2.28
Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med (1994) 1.73
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol (1989) 1.53
Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J Clin Microbiol (1983) 1.51
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology (1992) 1.18
A population-based seroepidemiological study of cervical cancer. Cancer Res (1994) 1.17
Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer (1990) 1.13
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A (1989) 1.13
Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners. J Med Virol (1992) 1.12
[HIV prevalence among heterosexual subjects with multiple partners in Amsterdam]. Ned Tijdschr Geneeskd (1990) 1.06
Heterosexuals at risk for HIV: differences between private and commercial partners in sexual behaviour and condom use. AIDS (1989) 1.02
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J Virol (1991) 1.01
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J Virol (1991) 0.96
Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1. J Gen Virol (1990) 0.92
Limited changes in sexual behaviour of heterosexual men and women with multiple partners in The Netherlands. AIDS Care (1991) 0.90
Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. Int J Cancer (1992) 0.89
Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. J Gen Virol (1991) 0.87
Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am J Obstet Gynecol (1990) 0.86
Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera. J Gen Virol (1992) 0.86
Characterization of the humoral immune response to genital papillomaviruses. Mol Biol Med (1990) 0.84
Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. J Clin Microbiol (1992) 0.84
Increase in unsafe homosexual behaviour. Lancet (1990) 9.17
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med (1993) 7.21
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest (1994) 4.63
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet (1989) 4.19
HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS (1992) 3.91
Preventing AIDS in drug addicts in Amsterdam. Lancet (1986) 3.77
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70
Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS (1988) 3.50
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst (2001) 3.28
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) (1986) 3.27
Needlestick injuries, surgeons, and HIV risks. Lancet (1990) 3.26
Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis (1992) 3.16
Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ (1989) 3.16
Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med (1997) 3.08
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed) (1986) 2.75
Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. J Thromb Haemost (2007) 2.72
A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol (1993) 2.61
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J Virol (1987) 2.55
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol (1995) 2.50
Screening for syphilis among homosexual men in bars and saunas in Amsterdam. Br J Vener Dis (1982) 2.42
An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proc Natl Acad Sci U S A (1986) 2.42
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS (2001) 2.41
Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc Natl Acad Sci U S A (1984) 2.40
Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet (1988) 2.38
Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS (1992) 2.35
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci U S A (1986) 2.34
Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol (1987) 2.32
The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol (1992) 2.28
Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health (1989) 2.24
Declining gonorrhoea rates in The Netherlands, 1976-88: consequences for the AIDS epidemic. Genitourin Med (1990) 2.18
Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol (1996) 2.18
Euthanasia and physician-assisted suicide in homosexual men with AIDS. Lancet (1996) 2.15
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science (1996) 2.12
Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands. Am J Public Health (1988) 2.07
Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis (1988) 2.06
Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis (1990) 2.06
Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol (2000) 2.05
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) (1987) 2.02
Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst (1995) 2.01
[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]. Ned Tijdschr Geneeskd (1999) 1.94
BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins. Proc Natl Acad Sci U S A (1988) 1.91
Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS (1998) 1.89
Young and recent-onset injecting drug users are at higher risk for HIV. Addiction (1997) 1.88
HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission. Genitourin Med (1989) 1.88
A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis (1997) 1.87
[Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies and innovative methods for detecting infected individuals]. Ned Tijdschr Geneeskd (2007) 1.87
Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J (Clin Res Ed) (1983) 1.86
Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS (1993) 1.85
Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci U S A (1993) 1.77
Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol (1994) 1.77
Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect (2001) 1.76
Epidemiology of PPNG infections in Amsterdam: analysis by auxanographic typing and plasmid characterisation. Br J Vener Dis (1984) 1.75
Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis (1994) 1.75
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence]. Ned Tijdschr Geneeskd (1999) 1.74
Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med (1994) 1.73
The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS (1989) 1.71
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol (2005) 1.70
Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax (2008) 1.68
The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health (2001) 1.66
Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS (1995) 1.63
The importance of ethnicity as a risk factor for STDs and sexual behaviour among heterosexuals. Genitourin Med (1991) 1.62
Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med (2009) 1.60
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Role of male prostitutes in spread of sexually transmitted diseases and human immunodeficiency virus. Genitourin Med (1988) 1.58
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. J Thromb Haemost (2008) 1.55
Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin Med (1996) 1.54
Do gender differences in CD4 cell counts matter? AIDS (1999) 1.54
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Vaccine (2009) 1.52
Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Clin Infect Dis (1997) 1.51
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg (1998) 1.49
[The molecular epidemiology of hepatitis A in The Netherlands; the usefulness of typing isolated viral strains]. Ned Tijdschr Geneeskd (2007) 1.49
Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen. EMBO J (1985) 1.48
[Sexually transmissible diseases in heroin-addicted prostitutes in Amsterdam 1982]. Ned Tijdschr Geneeskd (1984) 1.47
No serological evidence for non-sexual spread of HPV16. Lancet (1994) 1.47
[Legionella outbreak in Amsterdam: a cooling tower as the source]. Ned Tijdschr Geneeskd (2006) 1.44
Risk factors and changes in sexual behavior in male homosexuals who seroconverted for human immunodeficiency virus antibodies. Am J Epidemiol (1990) 1.43
Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection. AIDS (1987) 1.43
Detection of HIV antibodies in saliva as a tool for epidemiological studies. AIDS (1992) 1.42
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains. AIDS (2001) 1.42
Characterization of RNA-mediated resistance to tomato spotted wilt virus in transgenic tobacco plants. Biotechnology (N Y) (1992) 1.42
A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J Gen Virol (1997) 1.42
[The spread of penicillinase-forming gonococci in Amsterdam]. Ned Tijdschr Geneeskd (1982) 1.41